Navigation Links
Aflac Japan To Offer Cancer Insurance Product Through Japan Post
Date:11/16/2007

COLUMBUS, Ga., Nov. 16 /PRNewswire-FirstCall/ -- Aflac Incorporated announced today that Japan Post Network Co., Ltd., a subsidiary of Japan Post Holdings Co., Ltd., has selected Aflac Japan as the exclusive provider of cancer insurance for distribution through the nationwide postal office network.

Japan Post Network Co. is one of four separate postal entities that began operating in October 2007 as a part of the postal privatization process set forth under laws enacted in 2005. Japan Post Network Co. operates approximately 24,000 post office locations throughout Japan.

Commenting on the announcement, Aflac Incorporated Chairman and Chief Executive Officer Daniel P. Amos said: "We are very pleased that Japan Post chose our cancer insurance product for sale through its extensive network. We believe Japan Post's selection of Aflac reflects the quality of our newly introduced Cancer Forte product, the overall strength of the Aflac brand, a reputation for quality customer service and the support we provide to our sales force. Although Japan Post has not yet established a specific time frame for sales to commence, we anticipate that sales should occur sometime in 2008."

Amos added: "Throughout 2007, we have been encouraged by the overall direction of Aflac Japan's new annualized premium sales. We continue to believe that our sales will be flat to up 4% in the second half of 2007. And although we have not yet finalized our marketing plans and objectives for 2008, our preliminary expectation is that Aflac Japan's sales should increase 3% to 7% next year."

For more than 50 years, Aflac products have given policyholders the opportunity to direct cash where it is needed most when a life-interrupting medical event causes financial challenges. Aflac is the number one provider of guaranteed-renewable insurance in the United States and the number one insurance company in terms of individual insurance policies in force in Japan. Our insurance product
'/>"/>

SOURCE Aflac Incorporated
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Aflac Announces Resignation of U.S. Marketing Officer
2. Aflac Incorporated to Release Third Quarter Results On October 23, 2007
3. Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend
4. Aflac Honors Hispanic Entrepreneurs Making a Difference in Texas
5. ESMO, Oxford Journals and the Japanese Society of Medical Oncology announce collaboration
6. Stille and Enova Form Strategic Partnership to Introduce Worlds Brightest LED Cordless Surgical Headlights Into Europe and Japan
7. ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan
8. Keiko Hattori Joins Haemonetics as President of Haemonetics Japan
9. Mannatech Hosts Japan National Convention
10. STAAR Surgical to Purchase Canons Interest in Japanese Joint Venture
11. Abaxis Announces Appointment of New Distribution Partner in Japan

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...o more letters from the North Pole, Textsanta.net ...s from Santa , North Pole...al efficiencies at the North Pole Santa Claus has ... over the globe informed of his Christmas progress...earch department have identified a large and growi...
(Date:11/25/2009)...PRNewswire-USNewswire/--Whenmostpeopleheartheacron...lsogivepatientsthehelptheyneed.TMJstandsfortheTemp...contacts/connectswithyourskull(temporalbone). ,...narepainwithchewing,clickingorpoppingofthejaw.Butm...ding:headaches,fatigue,sleepdisturbances,irritabil...
(Date:11/25/2009)...v.25/PRNewswire/--Thanksgivingmealswillbedelivered...ngBeachareathankstoFaithInAction/VolunteerActionfo...divisionofSCANHealthPlan.Formorethan17yearstheseor...erwarmThanksgivingmealstoseniorsinneedinLongBeach,...roundingcities. ,, "Ourwarmholidaymealsaredeliv...
(Date:11/25/2009)...sticular cancer who were treated with cisplatin-ba...luding neurological side effects and Raynaud-like ...otherapy, according to a new study published onlin...er Institute . , Marianne Brydy, M.D., of the De...l, in Bergen, Norway, and colleagues conducted a c...
(Date:11/25/2009)...fight rheumatoid arthritis, could help newly diagn...Y, Nov. 25 (HealthDay News) -- A drug commonly use...rthritis now also shows some promise in helping pa...The drug, rituximab (Rituxan), helped patients kee... the disease had destroyed some of their pancreati...
Breaking Medicine News(10 mins):Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
...ts at the Ohio State University have discovered a ...ainst the invasion of the HIV/AIDS virus. //It was...f injured DNA also destroy the DNA of the HIV viru...this discovery might lead to newer treatments targ...
...ts in Canada has said that choosing and eating the...erapy in lowering the cholesterol level//. Da...y of Toronto studied people who ate a diet high in... The participants, including 66 women and me...
...een proposed by the Ohio-based Cleveland Clinic, t...is summer, the services which would benefit Canadi...or medical treatment. The Cleveland clinic houses ...addition to information on health care options ava...
...ar study was conducted by the psychiatrist Dr Char... was backed by the National Institutes of Health//...fect of treating depression using drugs and psycho...onger periods, perhaps even for life, in patients ...
...epartment of New South Wales has conducted a study... serious impact on the user's physical health// . ...al health conditions. Cannabis abuse can lead to c... Wales Health Minister John Hatzistergos will open...
...ers at Yale shed new light on the mechanism of ner...a molecular "motor" protein, myosin-II, according ...Biology. As nerve cells develop or attempt to re...er to direct advance of the nerve cells and it has...
Other Medicine News:Health News:Satellite Clinic To Be Set Up in Toronto By Ohio-Based Cleveland Clinic 2Health News:Drugs Are Effective In Treating Depression and Preventing Recurrence 2Health News:A New Focus For The Mechanism Of Nerve Growth 2
(Date:11/25/2009)...lif.,Nov.25/PRNewswire-FirstCall/--Abaxis,Inc.(Nas...int-of-carebloodanalysissystems,announcedtodaythat...lpresentatthe21stAnnualPiperJaffrayHealthCareConfe...ferencewillbeheldattheNewYorkPalaceHotelinNewYorkC...facturesandmarketsportablebloodanalysissystemsforu...
(Date:11/25/2009)....25/PRNewswire-FirstCall/--NuVasive,Inc.(Nasdaq: N...uctsforminimallydisruptivesurgicaltreatmentsforthe...nMonday,November30,2009,at5:30p.m.ET/2:30p.m.PT.Th...eimbursementfortheCompany,sproductsandwillincludec...swersession.Thedial-innumbersare1-877-407-4018ford...
(Date:11/25/2009)...25/PRNewswire/--Reportlinker.comannouncesthatanewm..., IntranasalDrugDelivery-USMarketTrends&Analy...al-Drug-Delivery---US-Market-Trends--Analysis.html...inganexpansionoftherapeuticapplicationsfromthedeli...ryofsystemictherapeuticdrugs.Thefutureofthetechnol...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 1Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 2Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 3Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 4Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 59738 1Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 59738 2Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 59738 3Household Insecticides May Be Linked to Autoimmune Diseases 59735 1Household Insecticides May Be Linked to Autoimmune Diseases 59735 2Household Insecticides May Be Linked to Autoimmune Diseases 59735 3
...urnal Blood found 92 percent reduction in ... Conn., Aug. 20 Patients with a rare,blood disord...n the,incidence of life-threatening blood clots (t...culizumab), according to an analysis of clinical s...rnal of the American Society of,Hematology. Solir...
...1 Genaera,Corporation (Nasdaq: GENR ) today repo...initiated a multi-dose, Phase 2a clinical trial wi...ukin-9 (IL-9) in adults with,mild, persistent asth...is,designed to evaluate the safety and tolerabilit... the second Phase 2a study currently underway with...
Other Medicine Technology:PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 2PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 3PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 4PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 5PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 6PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 7PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 8Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program 2Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program 3Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program 4
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products: